摘要
背景:轻度认知障碍(MCI)是正常认知与痴呆之间的过渡状态。 目的:本研究的目的是在包括471个健忘MCI(a-MCI),693个健忘MCI多结构域的MCI类型的大型医院队列中研究血管危险因素,血管疾病,脑血管疾病和脑萎缩的作用(a-MCImd),322个单非存储器MCI(snm-MCI)和202个非遗忘MCI多域(na-MCImd)。为了比较,还评估了1005名神经和认知健康的受试者。 方法:评估几种血管危险因素和血管疾病。所有参与者接受神经学,神经心理学和行为评估以及颈动脉超声和标准脑MRI。使用NCI群组和a-MCI类型作为参考类别的MCI群组的多项式逻辑回归模型被用来评估评估变量对四种MCI类型之一的估计概率的影响。 结果:本研究表明,脑血管疾病对非记忆性MCI类型和α-MCImd类型的风险有很大贡献,并且脑萎缩存在于所有MCI类型中,并且在多种结构域类型中尤其如此,在na-MCI类型中更大。 结论:强制老年人改善脑血管病的检测和控制。由于MCI和痴呆的发病率预计会随着预期寿命的延长而上升,因此更好的脑血管疾病管理确实可以预防或延迟MCI的发病,或者可以延缓MCI向痴呆的进展
关键词: 轻度认知功能障碍类型,血管危险因素,血管疾病,丘疹,非腔隙性梗死,白质高信号,脑萎缩
Current Alzheimer Research
Title:Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Volume: 15 Issue: 7
关键词: 轻度认知功能障碍类型,血管危险因素,血管疾病,丘疹,非腔隙性梗死,白质高信号,脑萎缩
摘要: Background: Mild Cognitive Impairment (MCI) is a transitional state between normal cognition and dementia.
Objective: The aim of this study is to investigate the role of vascular risk factors, vascular diseases, cerebrovascular disease and brain atrophy in a large hospital-based cohort of MCI types including 471 amnestic MCI (a-MCI), 693 amnestic MCI multiple domain (a-MCImd), 322 single non-memory MCI (snm-MCI), and 202 non amnestic MCI multiple domain (na-MCImd). For comparison, 1,005 neurologically and cognitively healthy subjects were also evaluated.
Method: Several vascular risk factors and vascular diseases were assessed. All participants underwent neurological, neuropsychological and behavioural assessments as well as carotid ultrasonography and standard brain MRI. Multinomial logistic regression models on the MCI cohort with the NCH group and a-MCI type as reference categories were used to assess the effects of the variables evaluated on the estimated probability of one of the four MCI types.
Results: This study demonstrates that cerebrovascular disease contributes substantially to the risk of non-memory MCI types and a-MCImd type, and that brain atrophy is present in all MCI types and is greater in multiple domain types particularly in the na-MCI type.
Conclusion: Improving detection and control of cerebrovascular disease in aging individuals should be mandatory. Since the incidence of MCI and dementia will be expected to rise because of the progressive life expectancy, a better management of cerebrovascular disease could indeed prevent or delay the onset of MCI, or could delay progression of MCI to dementia.
Export Options
About this article
Cite this article as:
Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types, Current Alzheimer Research 2018; 15 (7) . https://dx.doi.org/10.2174/1567205015666180119110712
DOI https://dx.doi.org/10.2174/1567205015666180119110712 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Management of Prehypertension: Current Status and Future Strategies
Current Hypertension Reviews Current Genomics in Cardiovascular Medicine
Current Genomics Structure-Function Relationships of Plasminogen Activator Inhibitor-1 and Its Potential as a Therapeutic Agent
Current Drug Targets Minocycline Repurposing in Critical Illness: Focus on Stroke
Current Topics in Medicinal Chemistry Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Cardio-Protective Effects of Sodium-Glucose Co-Transporter 2 Inhibitors: Focus on Heart Failure
Current Pharmaceutical Design Algorithms and Criteria for Transcatheter Aortic Valve Replacement Patient Selection: Current Status and Future Trends
Current Pharmaceutical Design Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?
Current Pharmaceutical Design MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Oxidative Stress in Diabetic Nephropathy
Current Medicinal Chemistry Editorial (Thematic Issue: Inevitable Role of Traditional Systems of Medicine in Managing Non-Communicable Diseases (NCD))
Current Traditional Medicine Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Relaxin as a Cardiovascular Hormone: Physiology, Pathophysiology and Therapeutic Promises
Cardiovascular & Hematological Agents in Medicinal Chemistry Breast Cancer Chemoprevention: Current Perspectives
Current Enzyme Inhibition Disease Modification in Rheumatoid Arthritis and Osteoarthritis-Current and Emerging Targets and Therapeutics
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Impact of the CD40-CD40L Dyad in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Statins and Solid Organ Transplantation
Current Pharmaceutical Design Emerging Vascular Risk Factors in Women: Any Differences from Men?
Current Medicinal Chemistry Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design